Hamps Bio Limited (BOM:544312)
India · Delayed Price · Currency is INR 25.85
0.00 (0.00%)
At close: Jun 15, 2026
Hamps Bio Market Cap
Hamps Bio has a market cap or net worth of 225.21 million as of June 18, 2026.
Market Cap
225.21M
Enterprise Value
292.34M
Revenue
88.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.85
Market Cap Chart
Since December 20, 2024, Hamps Bio's market cap has decreased from 443.18M to 225.21M, a decrease of -49.18%. That is a compound annual growth rate of -36.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 225.21M | 29.25% |
| Dec 29, 2025 | 174.24M | -51.61% |
| Dec 31, 2024 | 360.11M | -18.74% |
| Dec 20, 2024 | 443.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panjon | 335.22M |
| JFL Life Sciences | 311.81M |
| Deccan Health Care | 303.36M |
| Gujarat Terce Laboratories | 272.62M |
| Parmax Pharma | 244.64M |
| Rekvina Laboratories | 230.39M |
| Walpar Nutritions | 225.84M |
| Cian Healthcare | 206.50M |